RESEARCHER PROFILE

M Hrubisko

← Back to Slovak Medical University

M

Slovak Medical University

Hematopoietic Stem Cell TransplantationBlood transfusion and managementHematological disorders and diagnosticsLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

M Hrubisko works in Hematopoietic Stem Cell Transplantation, Blood transfusion and management, Hematological disorders and diagnostics, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research. Recorded institutional associations include Slovak Medical University.

85Publications
778Citations
9H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

    2020 · 367 citations
  2. Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma

    2002 · 159 citations
  3. Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide

    2011 · 69 citations
  4. Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

    2016 · 46 citations
  5. The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents

    1993 · 37 citations
  6. Recommendations for the diagnosis and treatment of patients with polycythaemia vera

    2018 · 13 citations
  7. Chimerism 46,XX/46,XY in a phenotypic female

    1980 · 12 citations
  8. Isolated extra-medullary relapse of acute leukemia following allogeneic bone marrow transplantation.

    2008 · 11 citations
  9. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial

    2019 · 9 citations
  10. Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump

    1992 · 7 citations
  11. Drug resistance induction and cross-resistance studies with Pt-complexes.

    1984 · 6 citations
  12. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia – single center experience

    2017 · 6 citations
  13. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.

    1994 · 5 citations
  14. Is there still a role for autologous stem cell transplantation in acute myeloid leukemia?

    2012 · 5 citations
  15. In vivo and in vitro effectivity of some platinum complexes.

    1984 · 4 citations
  16. Allogeneic peripheral blood stem cell transplantations in children--a single center experience.

    2004 · 3 citations
  17. Cardiovascular complications among hematopoietic cell transplantation survivors – the role of cardiomarkers

    2022 · 3 citations
  18. [Osteoporosis in multiple myeloma].

    1998 · 2 citations
  19. [Autologous stem cell transplantation in a patient with juvenile chronic arthritis].

    1999 · 2 citations
  20. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.

    1973 · 2 citations
  21. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.

    1985 · 2 citations
  22. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.

    1989 · 2 citations
  23. Clinical experience and safety of venetoclax in the treatment of patients with chronic lymphocytic leukemia – real-world data from a hemato-oncology center

    2025 · 2 citations
  24. Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems.

    1986 · 1 citations
  25. [Cisplatin and its derivatives--effective antineoplastic agents].

    1987 · 1 citations

← Return to the university profile